Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate

• Published in: The Journal of pharmacology and experimental therapeutics Vol. 293; no. 3; pp. 755 - 760
• Main Authors: Malmsjö, M, Hou, M, Harden, T K, Pendergast, W, Pantev, E, Edvinsson, L, Erlinge, D
• Format: Journal Article
• Language: English
• Published: United States 01.06.2000
• Subjects: Adenosine Triphosphate - analogs & derivatives; Adenosine Triphosphate - pharmacology; Adolescent; Adult; Annan klinisk medicin; Cardiac and Cardiovascular Systems; Clinical Medicine; Coronary Vessels - drug effects; Coronary Vessels - physiology; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kardiologi; Klinisk medicin; Medical and Health Sciences; Medicin och hälsovetenskap; Middle Aged; Other Clinical Medicine; Polymerase Chain Reaction; Receptors, Purinergic P2 - drug effects; Receptors, Purinergic P2 - genetics; Receptors, Purinergic P2 - physiology; RNA, Messenger - analysis; Thionucleotides - pharmacology; Uridine Diphosphate - analogs & derivatives; Uridine Diphosphate - pharmacology; Uridine Triphosphate - analogs & derivatives; Uridine Triphosphate - pharmacology; Vasoconstriction - drug effects
• ISSN: 0022-3565; 1521-0103

The present study was designed to evaluate the relative contribution of the different contractile P2 receptors in endothelium-denuded human coronary arteries by use of extracellular nucleotides, including the stable pyrimidines uridine 5'-O-3-thiotriphosphate (UTPgammaS) and uridine 5'-O-thiodiphosphate (UDPbetaS). The isometric tension of isolated vessel segments was recorded in vitro, and P2 receptor mRNA expression was examined by reverse transcription-polymerase chain reaction. alphabeta-Methylene-adenosine triphosphate (alphabeta-MeATP) elicited contractions at a low concentration (pEC(50) = 5.2), indicating the presence of contractile P2X receptors. The P2Y responses were analyzed after P2X receptor desensitization with 10 microM alphabeta-MeATP. The stable nucleotides UTPgammaS and adenosine 5'-O-3-thiotriphosphate (ATPgammaS), which are agonists of P2Y(2) or P2Y(4) receptors, were approximately 2 log units more potent than the endogenous UTP and ATP (pEC(50) = 4.6 and 3.8 for UTPgammaS and ATPgammaS). The efficacy of these responses were approximately double that of the P2X agonist alphabeta-MeATP (E(max) = 125% for UTPgammaS, 126% for ATPgammaS, and 68% for alphabeta-MeATP), suggesting a primary role for contractile P2Y(2/4) receptors. The P2Y(2) receptor agonist diadenosine tetraphosphate also stimulated contraction, whereas the selective P2Y(1) agonist adenosine 5'-O-thiodiphosphate and the selective P2Y(6) agonist UDPbetaS had no effect. Reverse transcription-polymerase chain reaction analysis of mRNA from endothelium-denuded human coronary arteries demonstrated strong bands for P2Y(2) and P2X(1), although bands for P2Y(1), P2Y(4), and P2Y(6) receptor mRNA could also be detected. In conclusion, the stable pyrimidines UDPbetaS and UTPgammaS are important tools for P2 receptor subtype characterization in intact tissues with ectonucleotidase activity. Extracellular nucleotides elicit contraction of human coronary arteries primarily by activation of P2Y(2) and P2X receptors, whereas a role for P2Y(1) and P2Y(6) receptors can be excluded. Antagonists of P2Y(2) and P2X receptors may be useful in the treatment of coronary vasospastic disorders.